Selumetinib shrinks pediatric tumors, results of an early-phase clinical trial

(2:41)

Dr Jim Whittle, presenting: Selumetinib

(26:40)

NF and Selumetinib--update: After 9 months, I discontinued taking it because too many side effects.

(26)

Selumetinib in Children with Inoperable Plexiform Neurofibromas

(18:57)

Pharmacology of Selumetinib for treatment of Neurofibromatosis-1 (New Drug 2020)

(2:30)

Channel 7 News: PBS Listing for tumour shrinking medication, Koselugo

(1:47)

Caregiver Testimonial – Natalie’s Story with KOSELUGO® (selumetinib)

(9:18)

Let's Get the GIST Of It!: Understanding GIST Mutations \u0026 Clinical Trial Updates

(55:26)

212 Drugs in development for RAI-refractory differentiated thyroid cancer. New Molecular Targets

(57:15)

Treatment of Plexiform Neurofibroma - Ziad Khatib, MD

(24:6)

National Celebration Concert to End NF

(2:1:)

Litium and Methylene Blue

(8:19)

166 The ABCs of papillary and follicular thyroid cancer and variants: Understanding key terms...

(56:19)

#KeepResearchCurious webinar with René Bernards: 'My adventures with the MAP kinase pathway'

(1:2:57)

The Importance of Treating PN: Insights into Managing NF1 PN with Dr Sadighi

(18:51)

Dallas - 03x07 - Pam tells Bobby she has neurofibromatosis

(3:11)

2021 Clinical Research Forum Top 10| Selumetinib in Children with Inoperable Plexiform Neurofibromas

(1:34)

NF Summit 2022: Selumetinib - Clinical Trial Success Story

(46:9)

Activity of Selumetinib in Neurofibromatosis type 1 - Related Plexiform Neurofibromas

(19:7)

Selumetinib in children with inoperable plexiform Neurofibromas

(10:58)

Dr. Sherman Discusses the Development of Selumetinib

(47)

6 Important Facts about Koselugo® (selumetinib) for Treating Physicians

(9:35)

Interview with Brigitte Widemann, MD about Koselugo (selumetinib) the First FDA Approved Drug for NF

(15:34)

Activity of Selumetinib in Neurofibromatosis Type-Related Plexiform Neurofibromas

(6:55)

Selumetinib in children with recurrent or refractory low-grade glioma

(6:7)

Jane's Koselugo (Selumetinib) Success Story

(2:32)

Believe We Can End NF: Philip Moss 2017

(1:57)

Potential treatment for brain cancer as drug shrinks tumours

(1:30)

Dr. Richard Carvajal on Selumetinib/ Dacarbazine in Uveal Melanoma

(1:32)